Methotrexate in the treatment of ankylosing spondylitis

Scandinavian Journal of Rheumatology

Volumn 30, Issue 6, 2001, Pages 313-314

  Marshall, R W ^a   Kirwan, J R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Ankylosing spondylitis; Axial; Enthesitis; Methotrexate; Peripheral

Indexed keywords

METHOTREXATE; PLACEBO;

ANKYLOSING SPONDYLITIS; BONE MARROW; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; ENTHESITIS; HISTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; SPINE; SYNOVITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; METHOTREXATE; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 0035662399     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401317148480     Document Type: Short Survey

References (17)

1. Treatments used by patients with ankylosing spondylitis. Comparison with the treatment preferences of rheumatologists
2. Ankylosing spondylitis successfully treated with methotrexate
3. Second-line treatment in seronegative spondylarthropathies
4. Methotrexate in severe ankylosing spondylitis: An open study
5. Methotrexate in the treatment of ankylosing spondylitis
6. Ankylosing spondylitis: A late re-evaluation of 92 cases
7. The course of established ankylosing spondylitis and the effects of sulphasalazine over three years
8. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis
9. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis - Cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
10. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy
11. Enthesitis in spondyloarthropathy
12. Histopathology of diarthrodeal joints in ankylosing spondylitis
13. The microscopic appearances of synovial membranes in peripheral joints in ankylosing spondylitis
14. An immunohistological analysis of the synovial membrane in ankylosing spondylitis
15. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis
16. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies
17. Preliminary core sets for endpoints in ankylosing spondylitis